Copper(II)‐ and gold(III)‐mediated cyclization of a thiourea to a substituted 2‐aminobenzothiazole

Benzothiazole derivatives are a class of privileged molecules due to their biological activity and pharmaceutical applications. One route to these molecules is via intramolecular cyclization of thioureas to form substituted 2‐aminobenzothiazoles, but this often requires harsh conditions or employs expensive metal catalysts. Herein, the copper(II)‐ and gold(III)‐mediated cyclizations of thioureas to substituted 2‐aminobenzothiazoles are reported. The single‐crystal X‐ray structures of the thiourea N‐(3‐methoxyphenyl)‐N ′‐(pyridin‐2‐yl)thiourea, C₁₃H₁₃N₃OS, and the intermediate metal complexes aquabis[5‐methoxy‐N‐(pyridin‐2‐yl‐κN )‐1,3‐benzothiazol‐2‐amine‐κN ³]copper(II) dinitrate, [Cu(C₁₃H₁₁N₃OS)₂(H₂O)](NO₃)₂, and bis{2‐[(5‐methoxy‐1,3‐benzothiazol‐2‐yl)amino]pyridin‐1‐ium} dichloridogold(I) chloride monohydrate, (C₁₃H₁₂N₃OS)₂[AuCl₂]Cl·H₂O, are reported. The copper complex exhibits a distorted trigonal–bipyramidal geometry, with direct metal‐to‐benzothiazole‐ligand coordination, while the gold complex is a salt containing the protonated uncoordinated benzothiazole, and offers evidence that metal reduction (in this case, Au^III to Au^I) is required for the cyclization to proceed. As such, this study provides further mechanistic insight into the role of the metal cations in these transformations.     

A one‐dimensional silver(I) coordination polymer based on the 2‐[2‐(pyridin‐4‐yl)‐1H‐benzimidazol‐1‐ylmethyl]phenol ligand exhibiting photoluminescence

A one‐dimensional Ag^I coordination complex, catena‐poly[[silver(I)‐μ‐{2‐[2‐(pyridin‐4‐yl)‐1H‐benzimidazol‐1‐ylmethyl]phenol‐κ²N²:N³}] perchlorate monohydrate], {[Ag(C₁₉H₁₅N₃O)]ClO₄·H₂O}_n, was synthesized by the reaction of 2‐[2‐(pyridin‐4‐yl)‐1H‐benzimidazol‐1‐ylmethyl]phenol (L) with silver perchlorate. In the complex, the L ligands are arranged alternately and link Ag^I cations through one benzimidazole N atom and the N atom of the pyridine ring, leading to an extended zigzag chain structure. In addition, the one‐dimensional chains are extended into a three‐dimensional supramolecular architecture via O—H...O hydrogen‐bond interactions and π–π stacking interactions. The complex exhibits photoluminescence in acetonitrile solution, with an emission maximum at 390 nm, and investigation of the thermal stability reveals that the network structure is stable up to 650 K.     

Three AgI,CuI and CdII coordination polymers based on the new asymmetrical ligand 2‐{4‐[(1H‐imidazol‐1‐yl)methyl]phenyl}‐5‐(pyridin‐4‐yl)‐1,3,4‐oxadiazole: syntheses,characterization and emission properties

The new asymmetrical organic ligand 2‐{4‐[(1H‐imidazol‐1‐yl)methyl]phenyl}‐5‐(pyridin‐4‐yl)‐1,3,4‐oxadiazole ( L , C₁₇H₁₃N₅O), containing pyridine and imidazole terminal groups, as well as potential oxdiazole coordination sites, was designed and synthesized. The coordination chemistry of L with soft Ag^I, Cu^I and Cd^II metal ions was investigated and three new coordination polymers (CPs), namely, catena‐poly[[silver(I)‐μ‐2‐{4‐[(1H‐imidazol‐1‐yl)methyl]phenyl}‐5‐(pyridin‐4‐yl)‐1,3,4‐oxadiazole] hexafluoridophosphate], {[Ag( L )]PF₆}_n, catena‐poly[[copper(I)‐di‐μ‐iodido‐copper(I)‐bis(μ‐2‐{4‐[(1H‐imidazol‐1‐yl)methyl]phenyl}‐5‐(pyridin‐4‐yl)‐1,3,4‐oxadiazole)] 1,4‐dioxane monosolvate], {[Cu₂I₂( L )₂]·C₄H₈O₂}_n, and catena‐poly[[[dinitratocopper(II)]‐bis(μ‐2‐{4‐[(1H‐imidazol‐1‐yl)methyl]phenyl}‐5‐(pyridin‐4‐yl)‐1,3,4‐oxadiazole)]–methanol–water (1/1/0.65)], {[Cd( L )₂(NO₃)₂]·2CH₄O·0.65H₂O}_n, were obtained. The experimental results show that ligand L coordinates easily with linear Ag^I, tetrahedral Cu^I and octahedral Cd^II metal atoms to form one‐dimensional polymeric structures. The intermediate oxadiazole ring does not participate in the coordination interactions with the metal ions. In all three CPs, weak π–π interactions between the nearly coplanar pyridine, oxadiazole and benzene rings play an important role in the packing of the polymeric chains.     

Syntheses and characterization of dinuclear and tetranuclear AgI supramolecular complexes generated from symmetric and asymmetric molecular clips containing oxadiazole rings

A new asymmetric ligand, 5‐{3‐[5‐(4‐methylphenyl)‐1,3,4‐oxadiazol‐2‐yl]phenyl}‐2‐(pyridin‐3‐yl)‐1,3,4‐oxadiazole ( L5 ), which contains two oxadiazole rings, was synthesized and characterized. The assembly of symmetric 2,5‐bis(pyridin‐3‐yl)‐1,3,4‐oxadiazole ( L1 ) and asymmetric L5 with AgCO₂CF₃ in solution yielded two novel Ag^I complexes, namely catena‐poly[[di‐μ‐trifluoroacetato‐disilver(I)]‐bis[μ‐2,5‐bis(pyridin‐3‐yl)‐1,3,4‐oxadiazole]], [Ag₂(C₂F₃O₂)₂(C₁₂H₈N₄O)₂]_n or [Ag₂(μ₂‐O₂CCF₃)₂( L1 )₂]_n ( 1 ), and bis(μ₃‐5‐{3‐[5‐(4‐methylphenyl)‐1,3,4‐oxadiazol‐2‐yl]phenyl}‐2‐(pyridin‐3‐yl)‐1,3,4‐oxadiazole)tetra‐μ₃‐trifluoroacetato‐tetrasilver(I) dichloromethane monosolvate, [Ag₄(C₂F₃O₂)₄(C₂₂H₁₅N₅O₂)₂]·CH₂Cl₂ or [Ag₂(μ₃‐O₂CCF₃)₂( L5 )]₂·CH₂Cl₂ ( 2 ). Complex 1 displays a one‐dimensional ring–chain motif, where dinuclear Ag₂(CF₃CO₂)₂ units alternate with Ag₂( L1 )₂ macrocycles. This structure is different from previously reported Ag– L1 complexes with different anions. Complex 2 features a tetranuclear supramolecular macrocycle, in which each ligand adopts a tridentate coordination mode with the oxadiazole ring next to the p‐tolyl ring coordinated and that next to the pyridyl ring free. Two L5 ligands are bound to two Ag1 centres through two oxadiazole N and two pyridyl N atoms to form a macrocycle. The other two oxadiazole N atoms coordinate to the two Ag2 centres of the Ag₂(O₂CCF₃)₄ dimer. Each CF₃CO₂^? anion adopts a μ₃‐coordination mode, bridging the Ag1 and Ag2 centres to form a tetranuclear silver(I) complex. This study indicates that the donor ability of the bridging oxadiazole rings can be tuned by electron‐withdrawing and ‐donating substituents. The emission properties of ligands L1 and L5 and complexes 1 and 2 were also investigated in the solid state.     

A new three‐dimensional silver(I) coordination framework with a diamondoid topology constructed from 2‐(pyridin‐4‐yl)‐1H‐imidazole‐4,5‐dicarboxylic acid

The title compound, poly[[μ₄‐5‐carboxy‐4‐carboxylato‐2‐(pyridin‐4‐yl)‐1H‐imidazol‐1‐ido]disilver(I)], [Ag₂(C₁₀H₅N₃O₄)]_n, was synthesized by reacting silver nitrate with 2‐(pyridin‐4‐yl)‐1H‐imidazole‐4,5‐dicarboxylic acid (H₃PyIDC) under hydrothermal conditions. The asymmetric unit contains two crystallographically independent Ag^I cations and one unique HPyIDC²⁻ anion. Both Ag^I cations are three‐coordinated in distorted T‐shaped coordination geometries. One Ag^I cation is coordinated by one N and two O atoms from two HPyIDC²⁻ anions, while the other is bonded to one O and two N atoms from two HPyIDC²⁻ anions. It is interesting to note that the HPyIDC²⁻ group acts as a μ₄‐bridging ligand to link the Ag^I cations into a three‐dimensional framework, which can be simplified as a diamondoid topology. The thermal stability and photoluminescent properties of the title compound have also been studied.     

A novel two‐dimensional metal–organic supramolecular framework including π–π stacking and hydrogen‐bond interactions

[μ‐N,N′‐Bis(pyridin‐3‐yl)benzene‐1,4‐dicarboxamide‐<!?show [forcelb]><!?tlsb=0.12pt>1:2κ²N:N′]bis{[N,N′‐bis(pyridin‐3‐yl)benzene‐1,4‐dicarboxamide‐κN]diiodidomercury(II)}, [Hg₂I₄(C₁₈H₁₄N₄O₂)₃], is an S‐shaped dinuclear molecule, composed of two HgI₂ units and three N,N′‐bis(pyridin‐3‐yl)benzene‐1,4‐dicarboxamide (L) ligands. The central L ligand is centrosymmetric and coordinated to two Hg^II cations via two pyridine N atoms, in a syn–syn conformation. The two terminal L ligands are monodentate, with one uncoordinated pyridine N atom, and each adopts a syn–anti conformation. The HgI₂ units show highly distorted tetrahedral (sawhorse) geometry, as the Hg^II centres lie only 0.34 (2) or 0.32 (2) Å from the planes defined by the I and pyridine N atoms. Supramolecular interactions, thermal stability and solid‐state luminescence properties were also measured.     

Counter‐anion role in the formation of two supramolecular complexes: [Ag2(DPP)2](ClO4)2·CH3CN and [Ag2(DPP)2(NO3)2] {DPP is N‐[(diphenylphosphanyl)methyl]pyridin‐4‐amine}

The title compounds, bis{μ‐N‐[(diphenylphosphanyl)methyl]pyridin‐4‐amine‐κ²N¹:P}disilver bis(perchlorate) acetonitrile monosolvate, [Ag₂(C₁₈H₁₇N₂P)₂](ClO₄)₂·CH₃CN, (1), and bis{μ‐N‐[(diphenylphosphanyl)methyl]pyridin‐4‐amine‐κ²N¹:P}bis[(nitrato‐κ²O,O)silver], [Ag₂(C₁₈H₁₇N₂P)₂(NO₃)₂], (2), each contain disilver macrocyclic [Ag₂(C₁₈H₁₇N₂P)₂]²⁺ cations lying about inversion centres. The cations are constructed by two N‐[(diphenylphosphanyl)methyl]pyridin‐4‐amine (DPP) ligands linking two Ag⁺ cations in a head‐to‐tail fashion. In (1), the unique Ag⁺ cation has a near‐linear coordination geometry consisting of one pyridine N atom and one P atom from two different DPP ligands. Two ClO₄⁻ anions doubly bridge two metallomacrocycles through Ag...O and N—H...O weak interactions to form a chain extending in the c direction. The half‐occupancy acetonitrile molecule lies with its methyl C atom on a twofold axis and makes a weak N...Ag contact. In (2), there are two independent [Ag(C₁₈H₁₇N₂P)]⁺ cations. The nitrate anions weakly chelate to each Ag⁺ cation, leading to each Ag⁺ cation having a distorted tetrahedral coordination geometry consisting of one pyridine N atom and one P atom from two different DPP ligands, and two chelating nitrate O atoms. Each dinuclear [Ag₂(C₁₈H₁₇N₂P)₂(NO₃)₂] molecule acts as a four‐node to bridge four adjacent equivalent molecules through N—H...O interactions, forming a two‐dimensional sheet parallel to the bc plane. Each sheet contains dinuclear molecules involving just Ag1 or Ag2 and these two types of sheet are stacked in an alternating fashion. The sheets containing Ag1 all lie near x = , , etc, while those containing Ag2 all lie near x = 0, 1, 2 etc. Thus, the two independent sheets are arranged in an alternating sequence at x = 0, , 1, etc. These two different supramolecular structures result from the different geometric conformations of the templating anions which direct the self‐assembly of the cations and anions.     

Syntheses,Characterization, and Crystal Structures of a Dinuclear Complex and Coordination Polymer of Mercury(II) with Schiff Base Ligands containing N3 and N4 Donors

Two dinuclear mercury(II) iodide compounds, [Hg₂(L)(I)₄] ( 1 ) and [(L′)Hg(μ‐I)₂HgI₂]_n ( 2 ) [L = N,N′‐bis(phenyl(pyridin‐2‐yl)methylene)propane‐1,2‐diamine and L′ = N‐(phenyl(pyridin‐2‐yl)methylene)propane‐1,2‐diamine] were synthesized and characterized. The molecular structures of [Hg₂(L)(I)₄] ( 1 ) and [(L′)Hg(μ‐I)₂HgI₂]_n ( 2 ), which were determined by single‐crystal X‐ray diffraction, indicate that each Hg^II in 1 has a distorted tetrahedral environment around the metal atom with a HgN₂I₂ chromophore, whereas in 2 one mercury(II) atom adopts a distorted tetrahedral arrangement with a HgI₄ chromophore and the other has a distorted square pyramidal environment with HgN₃I₂ chromophore. In the solid state, compound 2 consists of a 1D coordination polymer structure.     

Tuning of crystallization method and ligand conformation to give a mononuclear compound or two‐dimensional SCO coordination polymer based on a new semi‐rigid V‐shaped bis‐pyridyl bis‐amide ligand

With the new semi‐rigid V‐shaped bidentate pyridyl amide compound 5‐methyl‐N,N′‐bis(pyridin‐4‐yl)benzene‐1,3‐dicarboxamide (L) as an auxiliary ligand and the Fe^II ion as the metal centre, one mononuclear complex, bis(methanol‐κO)bis[5‐methyl‐N,N′‐bis(pyridin‐4‐yl)benzene‐1,3‐dicarboxamide‐κN]bis(thiocyanato‐κN)iron(II), [Fe(SCN)₂(C₁₉H₁₆N₄O₂)₂(CH₃OH)₂] ( 1 ), and one two‐dimensional coordination polymer, catena‐poly[[[bis(thiocyanato‐κN)iron(II)]‐bis[μ‐5‐methyl‐N,N′‐bis(pyridin‐4‐yl)benzene‐1,3‐dicarboxamide‐κ²N:N′]] methanol disolvate dihydrate], {[Fe(SCN)₂(C₁₉H₁₆N₄O₂)₂]·2CH₃OH·2H₂O}_n ( 2 ), were prepared by slow evaporation and H‐tube diffusion methods, respectively, indicating the effect of the method of crystallization on the structure type of the target product. Both complexes have been structurally characterized by elemental analysis, IR spectroscopy and single‐crystal X‐ray crystallography. The single‐crystal X‐ray diffraction analysis shows that L functions as a monodentate ligand in mononuclear 1 , while it coordinates in a bidentate manner to two independent Fe(SCN)₂ units in complex 2 , with a different conformation from that in 1 and the ligands point in two almost orthogonal directions, therefore leading to a two‐dimensional grid‐like network. Investigation of the magnetic properties reveals the always high‐spin state of the Fe^II centre over the whole temperature range in 1 and a gradual thermally‐induced incomplete spin crossover (SCO) behaviour below 150 K in 2 , demonstrating the influence of the different coordination fields on the spin properties of the metal ions. The current results provide useful information for the rational design of functional complexes with different structure dimensionalities by employing different conformations of the ligand and different crystallization methods.     

Structural studies of (prop‐2‐en‐1‐yl)bis[(pyridin‐2‐yl)methylidene]amine hetero‐scorpionate copper complexes

The structures of five compounds consisting of (prop‐2‐en‐1‐yl)bis[(pyridin‐2‐yl)methylidene]amine complexed with copper in both the Cu^I and Cu^II oxidation states are presented, namely chlorido{(prop‐2‐en‐1‐yl)bis[(pyridin‐2‐yl)methylidene]amine‐κ³N,N′,N′′}copper(I) 0.18‐hydrate, [CuCl(C₁₅H₁₇N₃)]·0.18H₂O, (1), catena‐poly[[copper(I)‐μ₂‐(prop‐2‐en‐1‐yl)bis[(pyridin‐2‐yl)methylidene]amine‐κ⁵N,N′,N′′:C²,C³] perchlorate acetonitrile monosolvate], {[Cu(C₁₅H₁₇N₃)]ClO₄·CH₃CN}_n, (2), dichlorido{(prop‐2‐en‐1‐yl)bis[(pyridin‐2‐yl)methylidene]amine‐κ³N,N′,N′′}copper(II) dichloromethane monosolvate, [CuCl₂(C₁₅H₁₇N₃)]·CH₂Cl₂, (3), chlorido{(prop‐2‐en‐1‐yl)bis[(pyridin‐2‐yl)methylidene]amine‐κ³N,N′,N′′}copper(II) perchlorate, [CuCl(C₁₅H₁₇N₃)]ClO₄, (4), and di‐μ‐chlorido‐bis({(prop‐2‐en‐1‐yl)bis[(pyridin‐2‐yl)methylidene]amine‐κ³N,N′,N′′}copper(II)) bis(tetraphenylborate), [Cu₂Cl₂(C₁₅H₁₇N₃)₂][(C₆H₅)₄B]₂, (5). Systematic variation of the anion from a coordinating chloride to a noncoordinating perchlorate for two Cu^I complexes results in either a discrete molecular species, as in (1), or a one‐dimensional chain structure, as in (2). In complex (1), there are two crystallographically independent molecules in the asymmetric unit. Complex (2) consists of the Cu^I atom coordinated by the amine and pyridyl N atoms of one ligand and by the vinyl moiety of another unit related by the crystallographic screw axis, yielding a one‐dimensional chain parallel to the crystallographic b axis. Three complexes with Cu^II show that varying the anion composition from two chlorides, to a chloride and a perchlorate to a chloride and a tetraphenylborate results in discrete molecular species, as in (3) and (4), or a bridged bis‐μ‐chlorido complex, as in (5). Complex (3) shows two strongly bound Cl atoms, while complex (4) has one strongly bound Cl atom and a weaker coordination by one perchlorate O atom. The large noncoordinating tetraphenylborate anion in complex (5) results in the core‐bridged Cu₂Cl₂ moiety.     

The 3[ndσ*(n+1)pσ] Emissions of Linear Silver(I) and Gold(I) Chains with Bridging Phosphine Ligands

The complexes [Au₃(dcmp)₂][X]₃ {dcmp=bis(dicyclohexylphosphinomethyl)cyclohexylphosphine; X=Cl^? ( 1 ), ClO₄^? ( 2 ), OTf^? ( 3 ), PF₆^? ( 4 ), SCN^?( 5 )}, [Ag₃(dcmp)₂][ClO₄]₃ ( 6 ), and [Ag₃(dcmp)₂Cl₂][ClO₄] ( 7 ) were prepared and their structures were determined by X‐ray crystallography. Complexes 2 – 4 display a high‐energy emission band with λ_max at 442–452 nm, whereas 1 and 5 display a low‐energy emission with λ_max at 558–634 nm in both solid state and in dichloromethane at 298 K. The former is assigned to the ³[5dσ*6pσ] excited state of [Au₃(dcmp)₂]³⁺, whereas the latter is attributed to an exciplex formed between the ³[5dσ*6pσ] excited state of [Au₃(dcmp)₂]³⁺ and the counterions. In solid state, complex [Ag₃(dcmp)₂][ClO₄]₃ ( 6 ) displays an intense emission band at 375 nm with a Stokes shift of ≈7200 cm^?1 from the ¹[4dσ*→5pσ] absorption band at 295 nm. The 375 nm emission band is assigned to the emission directly from the ³[4dσ^*5pσ] excited state of 6 . Density functional theory (DFT) calculations revealed that the absorption and emission energies are inversely proportional to the number of metal ions (n) in polynuclear Au^I and Ag^I linear chain complexes without close metal???anion contacts. The emission energies are extrapolated to be 715 and 446 nm for the infinite linear Au^I and Ag^I chains, respectively, at metal???metal distances of about 2.93–3.02 Å. A QM/MM calculation on the model [Au₃(dcmp)₂Cl₂]⁺ system, with Au???Cl contacts of 2.90–3.10 Å, gave optimized Au???Au distances of 2.99–3.11 Å in its lowest triplet excited state and the emission energies were calculated to be at approximately 600–690 nm, which are assigned to a three‐coordinate Au^I site with its spectroscopic properties affected by Au^I???Au^I interactions.     

Synthesis,characterization and cytotoxicity of gold(III) complexes with deprotonated pyridyl carboxamide

Six new gold(III) complexes [Au(bzpam)Cl₂] (1, bzpamH = N‐benzyl picolinamide), [Au(hetpam)Cl₂] (2, hetpamH = N‐(2‐hydroxyethyl) picolinamide), [Au(pypam)Cl]AuCl₄ (3, pypamH = N‐(pyridin‐2‐ylmethyl) picolinamide), [Au(dmepam)Cl]AuCl₄ (4, dmepamH = N‐(2‐(dimethylamino)ethyl) picolinamide), [Au(bhetpydam)Cl] (5, bhetpydamH₂ = N,N′‐bis(2‐hydroxyethyl) pyridine‐ 2,6‐dicarboxamide) and [Au₂(hedam)Cl₄] (6, hedamH₂ = N,N′‐(hexane‐1,6‐diyl) dipicolinamide) with deprotonated pyridyl carboxamide were synthesized and characterized by elemental analysis, molar conductivity, IR, H¹ NMR and C¹³ NMR techniques. The analytical data showed that deprotonated pyridyl carboxamide coordinated with gold(III) ions through a nitrogen atom. The cytotoxicity against Bel‐7402 and HL‐60 cell lines was tested by MTT (3‐(4,5‐Dimethylthiazol‐2‐yl)‐2,5‐diphenyltetrazolium bromide) and SRB (sulforhodamine B) assays. The results indicated that the complexes exerted cytotoxic effects against Bel‐7402 and HL‐60 cell lines, complex 6 had better cytotoxicity than cisplatin, and complex 3 displayed similar cytotoxicity to cisplatin against Bel‐7402 cell line. The results suggested that the characteristics of ligands had an important effect on cytotoxicity of complexes. Copyright © 2012 John Wiley & Sons, Ltd.     

Structural studies and antileishmanial activity of 2‐acetylpyridine and 2‐benzoylpyridine nitroimidazole‐derived hydrazones

Three imidazole hydrazone compounds, namely 2‐(4‐nitro‐1H‐imidazol‐1‐yl)‐N′‐[1‐(pyridin‐2‐yl)ethylidene]acetohydrazide, C₁₂H₁₂N₆O₃, ( 1 ), 2‐(2‐nitro‐1H‐imidazol‐1‐yl)‐N′‐[1‐(pyridin‐2‐yl)ethylidene]acetohydrazide, C₁₂H₁₂N₆O₃, ( 2 ), and 2‐(2‐nitro‐1H‐imidazol‐1‐yl)‐N′‐[(phenyl)(pyridin‐2‐yl)methylidene]acetohydrazide, C₁₇H₁₄N₆O₃, ( 3 ), were obtained and fully characterized, including their crystal structure determinations. While all the compounds proved not to be cytotoxic to J774.A1 macrophage cells, ( 1 ) and ( 3 ) exhibited activity against Leishmania chagasi, whereas ( 2 ) was revealed to be inactive. Since both ( 1 ) and ( 3 ) exhibited antileishmanial effects, while ( 2 ) was devoid of activity, the presence of the acetyl or benzoyl groups was possibly not a determining factor in the observed antiprotozoal activity. In contrast, since ( 1 ) and ( 3 ) are 4‐nitroimidazole derivatives and ( 2 ) is a 2‐nitroimidazole‐derived compound, the presence of the 4‐nitro group probably favours antileishmanial activity over the 2‐nitro group. The results suggested that further investigations on compounds ( 1 ) and ( 3 ) as bioreducible antileishmanial prodrug candidates are called for.     

Synthesis and antibacterial activity of novel series of 2‐(p‐tolyloxy)‐3‐(5‐(pyridin‐4‐yl)‐1,3,4‐oxadiazol‐2‐yl)quinoline

A new series of 2‐(p‐tolyloxy)‐3‐(5‐(pyridin‐4‐yl)‐1,3,4‐oxadiazol‐2‐yl)quinoline were synthesized from oxidative cyclization of N′‐((2‐(p‐tolyloxy)quinoline‐3‐yl)methylene)isonicotinohydrazide in DMSO/I₂ at reflux condition for 3–4 h. The structures of the new compounds were confirmed by elemental analyses as well as IR, ¹H‐NMR, and mass spectral data. All the synthesized compounds were screened for their antibacterial activities against various bacterial strains. Several of these compounds showed potential antibacterial activity. J. Heterocyclic Chem., (2011).     

Two cobalt(II) supramolecular isomers based on N,N′‐bis(pyridin‐3‐yl)oxalamide induced by the molecular orientation of lattice DMF molecules

Supramolecular isomerism for coordination networks refers to the existence of different architectures having the same building blocks and identical stoichiometries. For a given building block, different arrangements can lead to the formation of a series of supramolecular isomers. Two one‐dimensional Co^II coordination polymers based on N,N′‐bis(pyridin‐3‐yl)oxalamide (BPO), both catena‐poly[[[dichloridocobalt(II)]‐bis[μ‐N,N′‐bis(pyridin‐3‐yl)oxalamide‐κ²N:N′]] dimethylformamide disolvate], {[CoCl₂(C₁₂H₁₀N₄O₂)₂]·2C₃H₇NO}_n, have been assembled by the solvothermal method. Single‐crystal X‐ray diffraction analyses reveal that the two compounds are supramolecular isomers, the isomerism being induced by the orientation of the dimethylformamide (DMF) molecules in the crystal lattice.     

The three‐dimensional coordination network in poly[di‐μ3‐cyanido‐μ5‐[5‐(pyridin‐4‐yl)tetrazolato]‐tricopper(I)]

In the title three‐dimensional tetrazolate‐based coordination polymer, poly[bis(μ₃‐cyanido‐κ³N:C:C)[μ₅‐5‐(pyridin‐4‐yl)tetrazolato‐κ⁵N:N′:N′′:N′′′:N′′′′]tricopper(I)], [Cu₃(C₆H₄N₅)(CN)₂]_n, there are two types of coordinated Cu^I atoms. One type exhibits a tetrahedral environment and the other, residing on a twofold axis, adopts a trigonal coordination environment. The closest Cu...Cu distance is only 2.531 (2) Å, involving a bridging cyanide C atom. All four tetrazolate and the pyridine N atom of the 4‐(pyridin‐4‐yl)‐1H‐tetrazolate anion are coordinated to these Cu^I atoms and exhibit a μ₅‐bridging mode. The three‐dimensional coordination network can be topologically simplified as a rarely observed (3,3,4,5)‐connected network with the Schläfli symbol (4.6.8⁴)₂.(4².6.8⁷).(6.8²)₃.     

Structural and spectroscopic characterization of two new blue luminescent pyridylbenzimidazole zinc(II) complexes

Luminescent metal complexes are used in photooptical devices. Zinc(II) complexes are of interest because of the ability to tune their color, their high thermal stability and their favorable carrier transport character. In particular, some zinc(II) complexes with aryl diimine and/or heterocyclic ligands have been shown to emit brightly in the blue region of the spectrum. Zinc(II) complexes bearing derivatized imidazoles have been explored for possible optoelectronic applications. The structures of two zinc(II) complexes of 5,6‐dimethyl‐2‐(pyridin‐2‐yl)‐1‐[(pyridin‐2‐yl)methyl]‐1H‐benzimidazole (L), namely dichlorido(dimethylformamide‐κO){5,6‐dimethyl‐2‐(pyridin‐2‐yl‐κN)‐1‐[(pyridin‐2‐yl)methyl]‐1H‐benzimidazole‐κN³}zinc(II) dimethylformamide monosolvate, [ZnCl₂(C₂₀H₁₈N₄)(C₃H₇NO)]·C₃H₇NO, (I), and bis(acetato‐κ²O,O′){5,6‐dimethyl‐2‐(pyridin‐2‐yl‐κN)‐1‐[(pyridin‐2‐yl)methyl]‐1H‐benzimidazole‐κN³}zinc(II) ethanol monosolvate, [Zn(C₂H₃O₂)₂(C₂₀H₁₈N₄)]·C₂H₅OH, (II), are reported. Complex (I) crystallized as a dimethylformamide solvate and exhibits a distorted trigonal bipyramidal coordination geometry. The coordination sphere consists of a bidentate L ligand spanning axial to equatorial sites, two chloride ligands in equatorial sites, and an O‐bound dimethylformamide ligand in the remaining axial site. The other complex, (II), crystallized as an ethanol solvate. The Zn^II atom has a distorted trigonal prismatic coordination geometry, with two bidentate acetate ligands occupying two edges and a bidentate L ligand occupying the third edge of the prism. Complexes (I) and (II) emit in the blue region of the spectrum. The results of density functional theory (DFT) calculations suggest that the luminescence of L results from π*←π transitions and that the luminescence of the complexes results from interligand charge‐transfer transitions. The orientation of the 2‐(pyridin‐2‐yl) substituent with respect to the benzimidazole system was found to have an impact on the calculated HOMO–LUMO gap (HOMO is highest occupied molecular orbital and LUMO is lowest unoccupied molecular orbital).     

Iron(III) Catecholates for Cellular Imaging and Photocytotoxicity in Red Light

Iron(III) complexes [Fe( L )( L′ )(NO₃)]—in which L is phenyl‐N,N‐bis[(pyridin‐2‐yl)methyl]methanamine ( 1 ), (anthracen‐9‐yl)‐N,N‐bis[(pyridin‐2‐yl)methyl]methanamine ( 2 ), (pyreny‐1‐yl)‐N,N‐bis[(pyridin‐2‐yl)methyl]methanamine ( 3 – 5 ), and L′ is catecholate ( 1 – 3 ), 4‐tert‐butyl catecholate ( 4 ), and 4‐(2‐aminoethyl)‐benzene‐1,2‐diolate ( 5 )—were synthesized and their photocytotoxic properties examined. The five electron‐paramagnetic complexes displayed a Fe^III/Fe^II redox couple near ?0.4 V versus a saturated calomel electrode (SCE) in DMF/0.1 m tetrabutylammonium perchlorate (TBAP). They showed unprecedented photocytotoxicity in red light (600–720 nm) to give IC₅₀≈15 μM in various cell lines by means of apoptosis to generate reactive oxygen species. They were ingested in the nucleus of HeLa and HaCaT cells in 4 h, thereby interacting favorably with calf thymus (ct)‐DNA and photocleaving pUC19 DNA in red light of 785 nm to form hydroxyl radicals.     

Novel one‐ and two‐dimensional ZnII coordination polymers based on a versatile 3,6‐bis(pyridin‐4‐yl)phenanthrene‐9,10‐dione ligand

Two new Zn^II coordination polymers, namely, catena‐poly[[dibromidozinc(II)]‐μ‐[3,6‐bis(pyridin‐4‐yl)phenanthrene‐9,10‐dione‐κ²N:N′]], [ZnBr₂(C₂₄H₁₄N₂O₂)]_n, (1), and poly[[bromido[μ₃‐10‐hydroxy‐3,6‐bis(pyridin‐4‐yl)phenanthren‐9‐olato‐κ³N:N′:O⁹]zinc(II)] hemihydrate], {[ZnBr(C₂₄H₁₅N₂O₂)]·0.5H₂O}_n, (2), have been synthesized through hydrothermal reaction of ZnBr₂ and a 60° angular phenanthrenedione‐based linker, i.e. 3,6‐bis(pyridin‐4‐yl)phenanthrene‐9,10‐dione, in different solvent systems. Single‐crystal analysis reveals that polymer (1) features one‐dimensional zigzag chains connected by weak C—H...π and π–π interactions to form a two‐dimensional network. The two‐dimensional networks are further stacked in an ABAB fashion along the a axis through C—H...O hydrogen bonds. Layers A and B comprise left‐ and right‐handed helical chains, respectively. Coordination polymer (2) displays a wave‐like two‐dimensional layered structure with helical chains. In this compound, there are two opposite helical –Zn–HL– chains [HL is 10‐hydroxy‐3,6‐bis(pyridin‐4‐yl)phenanthren‐9‐olate] in adjacent layers. The layers are packed in an ABAB sequence and are further connected through O—H...Br and O—H...O hydrogen‐bond interactions to form a three‐dimensional framework. In (1) and (2), the mutidentate L and HL ligands exhibits different coordination modes.     

Synthesis of some new Pyridine‐based Heterocyclic Compounds with Anticipated Antitumor Activity

A novel class of 5‐amino‐N′‐(1‐(pyridin‐4‐yl)ethylidene)‐1H‐pyrazole‐4‐carbohydrazides and 8‐(pyridin‐4‐yl)pyrido[2,3‐d][1,2,4]triazolo[4,3‐a]pyrimidin‐5(1H)‐ones was synthesized from reaction of 2‐cyano‐N′‐(1‐(pyridin‐4‐yl)ethylidene)‐acetohydrazide and 7‐(pyridin‐4‐yl)‐2‐thioxo‐2,3‐dihydropyrido[2,3‐d]pyrimidin‐4(1H)‐one with the appropriate hydrazonoyl halides. Moreover, 2‐cyano‐N′‐(1‐(pyridin‐4‐yl)‐ethylidene)‐acetohydrazide was used for the synthesis of 2‐cyano‐N′‐(1‐(pyridin‐4‐yl)ethylidene)‐acrylohydrazides and 2‐oxo‐2‐(2‐(1‐(pyridin‐4‐yl)ethylidene)‐hydrazinyl)‐acetohydrazonoyl cyanides. The structures of the newly prepared compounds were confirmed by both elemental and spectral analyses as well as by alternate synthesis. The anticancer activities of the prepared compounds were screened against the hepatocellular carcinoma (HepG2) cell line, and the results showed that most of the compounds exhibit considerable activities.